Idiopathic intracranial hypertension research hub
4 indexed studies · 1 currently recruiting
- authorisedTherapeutic confirmatory (Phase III)
Prevention of chronic headache with anti-CGRP antibody treatment in patients with idiopathic intracranial hypertension
This study is looking into a new treatment for chronic headaches in people with a condition called idiopathic intracranial hypertension. It's testing if a medicine that blocks a certain protein can help reduce or prevent these headaches. This is a big study, aiming to confirm if the treatment works.
Denmark - recruitingPhase III
IIH-Advance: A randomised clinical trial to determine the effects of weight loss, induced by a weight loss drug (Tirzepatide), in adults with active idiopathic intracranial hypertension
This study looks at whether a weight loss drug, Tirzepatide, can help adults with a condition called Idiopathic Intracranial Hypertension (IIH). IIH causes high pressure in the head, leading to headaches and eye problems. We want to see if losing weight with this drug can improve these symptoms.
United Kingdom · England · Northern Ireland - recruiting
Prospective Ocular Imaging for Intracranial Pressure Evaluation
This study is looking at pictures and videos of a tiny pulse at the back of your eye. This pulse can disappear when the pressure around your brain is too high. Researchers want to see if a computer program can learn to spot this pulse to help doctors check brain pressure without needing painful tests.
United Kingdom - ongoing, recruitingTherapeutic use (Phase IV)
Glucagone Like Peptide-1 Receptor (GLP-1R) Analogue Assisted Rapid Weight Loss Program as treatment of Idiopathic Intracranial Hypertension
This study looks at whether certain weight-loss medications (Wegovy, Ozempic) can help people with a condition called Idiopathic Intracranial Hypertension (IIH). Researchers want to see if losing weight quickly with these medicines can improve brain pressure and other symptoms over 8 weeks and then 10 months.
Denmark